ÂÜÀòÂÒÂ×

Elena Sanchez Viñes has a diverse work experience spanning over two decades. Their most recent role is as the Chief Operating Officer at Amadix, a company specializing in early cancer detection. Prior to this, they served as the Business Development Director at Amadix, where they worked on developing and commercializing innovative tests for screening and early diagnosis of colon, lung, and pancreatic cancer.

Before joining Amadix, Elena worked as a Strategic Consultant in the pharmaceutical and diagnostics industry. Elena demonstrated a deep understanding of the healthcare landscape and provided strategic analysis, healthcare provider profiling, and market insights to improve commercial and access strategies.

Elena also spent a significant portion of their career at Roche Farma España. Elena held various roles, including Franchise Head of Personalized HealthCare, where they successfully integrated diagnostics tools into the pharmaceutical unit. Elena also served as a Regional Access Manager, contributing to value creation and ensuring compliance with local regulatory processes. In addition, Elena worked as a Medical Manager in multiple oncology disease areas, providing scientific support, training, and launching several oncology products.

Before joining Roche, Elena gained experience as a Medical Scientific Liaison in oncology and as a Senior Clinical Research Associate, overseeing registry trials in the oncology field.

Elena began their career as a Clinical Research Associate at Pfizer.

Elena Sanchez Viñes has a diverse education history. In 1993, they began studying at Universidad Complutense de Madrid, where they pursued a Bachelor of Pharmacy degree in Biochemistry and Assitential Speciality. Elena completed their degree in 1998. In the same institution, they also completed a Master in Business Administration (MBA) with a specialization in Management and Business Administration in the Pharmaceutical Industry from 1998 to 1999.

In 2006, Elena enrolled in IE Business School, where they studied Managing and Direction in the Pharmaceutical Industry, completing the program in 2007. Elena returned to IE Business School in 2009 for an in-company program, earning a Master Directive Management. The specific field of study during this program is not mentioned.

In 2021, Elena attended another course at IE Business School, specifically an Executive Course on Artificial Intelligence with a focus on Digital Transformation. Their education history reflects a strong interest in the pharmaceutical industry, with additional training in business management and digital transformation.